Paper Details
- Home
- Paper Details
Original Abstract of the Article :
Single-dose pharmacokinetic studies were performed in 64 infants, ranging in age from less than 1 day to 6 days, after intravenous infusion or intramuscular injection of approximately 75 mg/kg of mezlocillin. Mean serum concentrations at one hour were 107 micrograms/ml and 82.5 micrograms/ml for neo...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://pubmed.ncbi.nlm.nih.gov/6478469
データ提供：米国国立医学図書館（NLM）
Clinical Evaluation of Mezlocillin in Neonates
This study focuses on the use of [mezlocillin], a type of antibiotic, in [neonates]. The researchers investigated the [pharmacokinetics and clinical efficacy of mezlocillin] in newborns. They conducted [single-dose pharmacokinetic studies] to determine the [optimal dosage and administration] of mezlocillin for neonates, and they also evaluated the [clinical effectiveness of mezlocillin] in treating [gram-negative bacterial infections]. The study found that [mezlocillin is an effective treatment option for gram-negative bacterial infections in neonates].
Mezlocillin: A Safe and Effective Antibiotic for Neonates
This research provides valuable data on the [use of mezlocillin in neonates]. The study demonstrated that [mezlocillin is safe and effective] for treating [gram-negative bacterial infections] in this vulnerable population. The researchers established [optimal dosing guidelines] for mezlocillin in neonates, ensuring that [appropriate therapeutic levels] are achieved while minimizing the risk of [adverse effects].
Improving Neonatal Care with Effective Antibiotic Therapy
This study highlights the importance of [appropriate antibiotic therapy] in [neonatal care]. The researchers emphasize that [selecting the right antibiotic] and [administering it correctly] is crucial for achieving a successful clinical outcome. The study's findings contribute to [the growing body of knowledge] on the use of antibiotics in neonates, helping to improve [the safety and effectiveness] of treatment for this vulnerable population.
Dr.Camel's Conclusion
This research provides a valuable resource for healthcare professionals caring for newborns. The study underscores the importance of selecting the right antibiotic and using it appropriately to ensure the best possible outcome for this fragile population. Just as a camel navigates the desert with careful steps, healthcare professionals must approach neonatal care with precision and attention to detail.
Date :
- Date Completed 1984-11-21
- Date Revised 2013-11-21
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.